A next-generation nutraceutical ingredient—cleaner, more sustainable, and ready for modern formulation needs.
BOULDER, CO — July 15, 2025 — DMC Biotechnologies (DMC), a leading U.S.-based biomanufacturer, announces the commercial launch of D-chiro-inositol. This new ingredient joins DMC’s growing portfolio of sustainable health actives, produced through fermentation, and now available for health-forward nutraceutical brands in the U.S.
Elevating the Standard Through Fermentation
DMC’s D-chiro-inositol is produced through a proprietary precision fermentation that is solvent-free, has a higher assurance of purity, and is significantly more sustainable than the incumbent process.
“We’re proud to introduce fermented D-chiro-inositol as a next generation ingredient for brands committed to clean and sustainable products” said Rusty Pittman, VP of Business Development at DMC. “In addition, consumers increasingly care how products are made—with fermentation emerging as a preferred alternative to chemical processing.”
D-Chiro-Inositol is a Key Ingredient for Supplements Targeting Metabolic Health and Ovarian Function
D-chiro-inositol is a naturally occurring isomer of inositol that is a popular ingredient in women’s health supplements and is often chosen to support menstrual, ovarian, and hormonal health, as well as maintain healthy insulin levels.1 D-chiro-inositol also has emerging applications in men’s health supplements. For instance, a recent clinical study showed D-chiro-inositol increased serum testosterone level in men by 23%.2
Building a Nutraceutical Portfolio and Sustainable Future
“The launch of D-chiro-inositol builds on the momentum of our recent introduction of myo-inositol,” said Jim Flatt, CEO of DMC. “Together, these products demonstrate DMC’s ability to quickly develop and commercialize important and sustainable human nutritional ingredients. We’re continuing to expand our pipeline of nutraceutical and cosmetic actives—bringing the same quality, transparency, and environmental responsibility to every product we introduce.”
This milestone supports DMC’s mission to decarbonize global supply chains and promote better health and wellness through cleaner and more sustainable ingredients.
The Complementary Roles of Myo-Inositol and D-Chiro-Inositol
Clinical trials suggest myo-inositol and D-chiro-inositol are more effective when formulated together, in various supplement applications that support menstrual, ovarian, and hormonal health. With both now available from DMC, nutraceutical brands can offer complete solutions utilizing our cleaner and more sustainable ingredients.
D-chiro-inositol is available for commercial use in the U.S. and select international markets.
To learn more about DMC Biotechnologies and its commitment to sustainable, high-performance ingredients, visit www.dmcbio.com.
Media Contact:
[email protected]
About DMC
DMC is a U.S.-based biomanufacturer redefining how the world produces chemicals. Through precision fermentation and synthetic biology, DMC creates sustainable, bio-based alternatives that reduce carbon emissions, enhance ingredient quality, and strengthen global supply chain resilience. The company’s proprietary platform, Dynamic Metabolic Control™, simplifies biological processes to enable predictable, scalable, and highly efficient fermentation—unlocking a new era of low-impact chemical manufacturing.
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease. The views and nutritional advice expressed by DMC Biotechnologies are not intended to be a substitute for conventional medical services.
- Giovanni Monastra, et al. June 3, 2021, Volume 31, Issue 1, Article 13, Basic Clinical Andrology “D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: a pilot study.”
